In addition to the NF-κB pathway, the molecular mechanisms of PTL involve anti-oxygen free radicals and changes in microtubule functions, and they inhibit tumor growth; as such, PTL can be used in numerous applications in clinical settings [8, 9]. Here, NFKB1 is linked to neoplasm.